The global beta-glucan market is segmented into source, application, type, and region.
On the basis of source, the market is segmented into cereal, mushroom, yeasts, and seaweed. The cereal segment is expected to contribute major revenue share in the global market in 2017, and is estimated to register lucrative growth in the next ten years. This is due to increasing demand for cereal based beta-glucan from bakery and other food industries globally.
On the basis of type, the market is segmented into soluble and insoluble. The soluble beta-glucan segment is expected to account for more than 50% of the revenue share in the global market in 2017, and is expected to continue its dominance during the forecast period, mainly due to rising demand for soluble type from pharmaceutical industry.
On the basis of application, the market is segmented into food & beverages, personal care & cosmetics, pharmaceuticals, animal feed, and health and dietary supplements. The food & beverages and pharmaceuticals segments are expected to lead in terms of revenue in the global market. The animal feed segment is expected to foresee an upsurge in terms of growth.
On the basis of region, the global beta-glucan market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Do Inquiry of the Report Here: https://marketresearch.biz/report/beta-glucan-market/#inquiry
Markets in North America and Europe are expected to lead the global beta-glucan market owing to presence of major manufacturers in Europe and high consumption rate of beta-glucan in countries in North America. Asia Pacific market is expected to witness lucrative growth in the next ten years.
Key players operating in the global market include Immunomedic AS, Cargill Incorporated, Tate & Lyle PLC, Biotec Pharmacon ASA, Biothera Pharmaceuticals, Inc., Kerry Group PLC, Super Beta Glucan Inc., Koninklijke DSM N.V., Garuda International, Inc., and Super Beta Glucan.